Management team

CEO

Gonzague Issenmann, MSc, MBA
Gonzague Issenmann is an experienced international executive, who worked and lived abroad for more than 10 years (US, Canada, Belgium and France). He was formerly at Cordis, Johnson & Johnson, and started his career in the automotive industry.
Combining a scientific and business education to a deep knowledge of the cardio-vascular industry, a broad functional expertise and an entrepreneurial spirit, Gonzague co-founded Stentys in 2005 and has been leading its development since then.

Chairman

Jacques Seguin, MD, PhD
Serial entrepreneur Jacques Seguin has been founding several medical technology companies in the cardio-vascular field in the last ten years. He is currently the Chairman and CEO of CoreValve, that developed its breakthrough Re-Valving technology to percutaneously replace the aortic valve.
As a surgeon, Jacques has a track record of more than 4,000 open-heart interventions; he is also the inventor of many patents and the author of more than 200 peer-reviewed international medical publications.

CTO

Hikmat Hojeibane
Hikmat Hojeibane is a R&D expert of the medtech industry with more than 19 years spent at companies like Johnson & Johnson, B Braun, CR Bard and Cryocath. Most of his time was spent at Cordis, J&J (cardiology business) in the development of advanced stent and catheter technologies. One of his major achievements was in the bifurcated stent area.

Director Regulatory Affairs

Luc Morisset
Luc Morisset is bringing 20 years of experience in EU regulatory affairs. Luc is a graduate from UTC University in Compiegne, France and holds a degree in biomedical engineering. He started his career as hospital biomedical engineer and then moved to the French Ministry of Health, where he was in charge of the pre-market approval for specific devices in France. Ten years ago, he joined MedPass International where he helped numerous companies by developing regulatory strategies to expedite CE marking and clinical trial approvals.